US 11357841
Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof
granted A61KA61K31/428A61K40/11
Quick answer
US patent 11357841 (Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof) held by Iovance Biotherapeutics, Inc. expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/428, A61K40/11, A61K40/42, A61K40/4205